DE69218795D1 - Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen - Google Patents

Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen

Info

Publication number
DE69218795D1
DE69218795D1 DE69218795T DE69218795T DE69218795D1 DE 69218795 D1 DE69218795 D1 DE 69218795D1 DE 69218795 T DE69218795 T DE 69218795T DE 69218795 T DE69218795 T DE 69218795T DE 69218795 D1 DE69218795 D1 DE 69218795D1
Authority
DE
Germany
Prior art keywords
learnability
connections
increase
neuro transmitters
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69218795T
Other languages
English (en)
Other versions
DE69218795T2 (de
Inventor
Wendell Wilkerson
Richard Earl
Matthew Voss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Publication of DE69218795D1 publication Critical patent/DE69218795D1/de
Application granted granted Critical
Publication of DE69218795T2 publication Critical patent/DE69218795T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69218795T 1992-01-16 1992-12-30 Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen Expired - Fee Related DE69218795T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82157292A 1992-01-16 1992-01-16
PCT/US1992/011292 WO1993014085A1 (en) 1992-01-16 1992-12-30 Novel neurotransmitter releasers useful for cognition enhancement

Publications (2)

Publication Number Publication Date
DE69218795D1 true DE69218795D1 (de) 1997-05-07
DE69218795T2 DE69218795T2 (de) 1997-07-10

Family

ID=25233729

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69218795T Expired - Fee Related DE69218795T2 (de) 1992-01-16 1992-12-30 Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen

Country Status (12)

Country Link
US (1) US5414004A (de)
EP (1) EP0623127B1 (de)
JP (1) JP2656157B2 (de)
AU (1) AU3425493A (de)
CA (1) CA2128233A1 (de)
DE (1) DE69218795T2 (de)
ES (1) ES2100523T3 (de)
IL (1) IL104417A0 (de)
MX (1) MX9300205A (de)
TW (1) TW215437B (de)
WO (1) WO1993014085A1 (de)
ZA (1) ZA93276B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW219935B (de) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
JPH08509713A (ja) * 1993-04-08 1996-10-15 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 認識疾患の治療に有用な神経伝達物質放出増強剤としての新規な多環式系およびその誘導体
US5594001A (en) * 1993-04-08 1997-01-14 The Dupont Merck Pharmaceutical Company Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
DE69533284T2 (de) * 1994-04-29 2005-07-21 Pfizer Inc. Neue cyclische und acyclische amide zur erhöhung der neurotransmitter ausschüttung
US5750528A (en) * 1995-02-01 1998-05-12 The Dupont Merck Pharmaceutical Company Blockade of neuronal m-channels as a therapeutic approach to the treatment of neurological disease
DK0810223T3 (da) * 1996-05-28 2001-09-24 Pfizer Adamantylsubstituerede oxindoler som farmaceutiske midler
JPH11236333A (ja) * 1997-12-30 1999-08-31 Pfizer Prod Inc 抗ガン剤として有用なイミダゾリン−４−オン誘導体
US20040175691A1 (en) * 1998-12-03 2004-09-09 Brown Barry S. Use of the KCNQ2 and KCNQ3 genes for the discovery of agents useful in the treatment of neurological disorders
US6174903B1 (en) 1998-12-28 2001-01-16 Pfizer Inc. Imidazolidin-4-one derivatives useful as anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US5206261A (en) * 1989-07-25 1993-04-27 Taiho Pharmaceutical Company, Limited Oxindole derivative
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Also Published As

Publication number Publication date
TW215437B (de) 1993-11-01
AU3425493A (en) 1993-08-03
MX9300205A (es) 1994-07-29
IL104417A0 (en) 1993-05-13
US5414004A (en) 1995-05-09
JP2656157B2 (ja) 1997-09-24
DE69218795T2 (de) 1997-07-10
JPH07503005A (ja) 1995-03-30
EP0623127B1 (de) 1997-04-02
CA2128233A1 (en) 1993-07-22
WO1993014085A1 (en) 1993-07-22
EP0623127A1 (de) 1994-11-09
ES2100523T3 (es) 1997-06-16
ZA93276B (en) 1994-07-15

Similar Documents

Publication Publication Date Title
DE3787829D1 (de) System für die Periodontaltasche zur kontrollierten Drogenfreisetzung.
DE3764024D1 (de) Fahrzeugbremssystem.
IT8123910A0 (it) Impianto frenante idraulico per veicoli.
TNSN97008A1 (fr) Thienyl et furanyl oxazolidinediones pyrido-condenses.
DE50001295D1 (de) Imidochromverbindungen in katalysatorsystemen für die olefinpolymerisation
NL194314B (nl) Foto-elektrisch omzettingssysteem.
DE68922081D1 (de) Optisches Multiplexsystem für die Verteilung elektrischer Energie, insbesondere für Fahrzeuge.
DE68911094D1 (de) Modulator für Blockierschutzbremssystem.
DE69218795D1 (de) Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen
DE3773216D1 (de) Blockiergeschuetztes bremssystem.
FR2662131B1 (fr) Circuit pour systeme hydraulique de freinage antiblocage.
ITRM910084A1 (it) Impianto frenante idraulico per veicoli stradali.
IT1215454B (it) Impianto di frenatura per veicoli a due ruote.
FI894257A0 (fi) Foerfarande foer framstaellning av ett optiskt aktivt system, i synnerhet att tillaempas pao ett fordons koerljus.
FR2668440B1 (fr) Systeme de freinage pour vehicule ferroviaire.
DE3866767D1 (de) Rahmenelementengruppe, um kabelbuendel zu realisieren.
IT8125651A0 (it) Impianto idraulico di frenatura per veicoli a due ruote.
DE59202933D1 (de) Anhängerbremsanlage.
DE68909240D1 (de) Anpassungsfähiges dreikanalbremssystem.
FR2683493B1 (fr) Dispositifs de securite anti-alcool notamment pour l'equipement de vehicules.
FR2720992B1 (fr) Système de freinage pour motocyclettes.
DE3771520D1 (de) Zeitstempelung fuer paketsystemknoten.
FR2670439B1 (fr) Agencement de circuit pour systeme de freinage anti-blocage.
FI913627A0 (fi) Katalysator foer metatesreaktioner av olefiner, foerfarande foer framstaellning av denna samt ifraogavarande metatesreaktion.
FR2666290B1 (fr) Modulateur pour systeme de freinage antiblocage.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DU PONT PHARMACEUTICALS CO., WILMINGTON, DEL., US

8339 Ceased/non-payment of the annual fee
8327 Change in the person/name/address of the patent owner

Owner name: BRISTOL-MYERS SQUIBB PHARMA CO., PRINCETON, N.J.,